Cooper Companies Inc (COO) Director Sells $179,812.10 in Stock

Cooper Companies Inc (NYSE:COO) Director Gary S. Petersmeyer sold 785 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $229.06, for a total value of $179,812.10. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Cooper Companies Inc (NYSE:COO) traded down $2.35 during midday trading on Thursday, reaching $228.64. The company had a trading volume of 660,200 shares, compared to its average volume of 517,745. The company has a current ratio of 2.41, a quick ratio of 1.26 and a debt-to-equity ratio of 0.36. Cooper Companies Inc has a one year low of $175.73 and a one year high of $256.39. The stock has a market cap of $11,170.00, a PE ratio of 30.40, a PEG ratio of 1.86 and a beta of 0.54.

Cooper Companies (NYSE:COO) last posted its quarterly earnings results on Thursday, December 7th. The medical device company reported $2.65 EPS for the quarter, topping the Zacks’ consensus estimate of $2.64 by $0.01. Cooper Companies had a return on equity of 16.02% and a net margin of 17.43%. The company had revenue of $561.50 million for the quarter, compared to analysts’ expectations of $558.86 million. During the same period in the previous year, the firm earned $2.28 EPS. The firm’s revenue was up 8.3% compared to the same quarter last year. sell-side analysts predict that Cooper Companies Inc will post 11.51 earnings per share for the current fiscal year.

The firm also recently declared a semiannual dividend, which will be paid on Friday, February 9th. Investors of record on Tuesday, January 23rd will be issued a $0.03 dividend. The ex-dividend date of this dividend is Monday, January 22nd. This represents a yield of 0.03%. Cooper Companies’s dividend payout ratio is presently 0.80%.

COO has been the subject of a number of recent research reports. Zacks Investment Research downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research note on Monday, September 18th. Raymond James Financial reiterated a “buy” rating and set a $265.00 price objective on shares of Cooper Companies in a research note on Monday, December 4th. Robert W. Baird set a $273.00 price objective on Cooper Companies and gave the company a “buy” rating in a research note on Monday, October 16th. BMO Capital Markets reiterated a “buy” rating and set a $272.00 price objective on shares of Cooper Companies in a research note on Friday, October 13th. Finally, Oppenheimer set a $250.00 price objective on Cooper Companies and gave the company a “hold” rating in a research note on Friday, December 8th. Seven research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Cooper Companies presently has a consensus rating of “Buy” and an average price target of $259.70.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Advisory Services Network LLC raised its holdings in shares of Cooper Companies by 30.6% during the 2nd quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock worth $109,000 after acquiring an additional 107 shares in the last quarter. YorkBridge Wealth Partners LLC raised its holdings in shares of Cooper Companies by 2.1% during the 2nd quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock worth $126,000 after acquiring an additional 11 shares in the last quarter. Acrospire Investment Management LLC raised its holdings in shares of Cooper Companies by 50.0% during the 2nd quarter. Acrospire Investment Management LLC now owns 600 shares of the medical device company’s stock worth $144,000 after acquiring an additional 200 shares in the last quarter. Canada Pension Plan Investment Board purchased a new stake in shares of Cooper Companies during the 3rd quarter worth approximately $163,000. Finally, Penserra Capital Management LLC raised its holdings in shares of Cooper Companies by 13.0% during the 2nd quarter. Penserra Capital Management LLC now owns 884 shares of the medical device company’s stock worth $211,000 after acquiring an additional 102 shares in the last quarter. 96.73% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: This article was originally posted by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at https://stocknewstimes.com/2018/01/12/cooper-companies-inc-coo-director-gary-s-petersmeyer-sells-785-shares-of-stock.html.

Cooper Companies Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Insider Buying and Selling by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply